← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Base Pair Biotechnologies, Inc.
Pearland, TX
$5,500,488
Total funding
10
Grants
Funding over time
peak $1.1M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,350,488 · 9
CDC$150,000 · 1
By mechanism
R44$3,221,461 · 2
N43$799,565 · 2
R43$660,679 · 3
N01$600,000 · 2
R41$218,783 · 1
Investigators at Base Pair Biotechnologies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection$751,525
R44 · FY2024 · EB
Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection$746,175
R44 · FY2025 · EB
Aptamer Reagents for Immunologic Analysis of Underrepresentative Mammalian Models of Tuberculosis$600,000
N43 · FY2019 · AI
Neonatal Opioid Screening Using Aptamers and Compensated Interferometry$582,503
R44 · FY2020 · DA
Neonatal Opioid Screening Using Aptamers and Compensated Interferometry$559,883
R44 · FY2021 · DA
IGF::OT::IGF Topic 372 Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics- Moonshot$300,000
N01 · FY2018 · CA
APTASENSORS FOR MEASURING LONG TERM ADHERENCE TO TENOFOVIR-BASED AND LONG ACTING HIV TREATMENT REGIMENS$300,000
N01 · FY2024 · DA
Aptamer engineering of lentiviral vectors for cardiac gene therapies$289,665
R43 · FY2023 · HL
Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection$266,072
R44 · FY2023 · EB
Rapid, Quantitative Point-of-Care Measurement of Tuberculosis Treatment Adherence$221,014
R43 · FY2020 · AI
Aptamers and BSI for Sub-Microliter Analysis of Pharmaceuticals in Neonatal Urine$218,783
R41 · FY2016 · HD
Neonatal Opioid Screening Using Aptamers and Compensated Interferometry$215,306
R44 · FY2019 · DA
TOPIC 319 PHASE I; TECHNOLOGY TO GENERATE ANTI PEPTICE CAPTURE REAGENS AFFINITY E$199,565
N43 · FY2013 · CA
SBIR, PA16-302, Point-of-care aptamer-based surface enhanced Raman scattering (aptamer-SERS) detection of malaria metabolites in urine and saliva$150,000
R43 · FY2017 · GH
Neonatal Opioid Screening Using Aptamers and Compensated Interferometry$99,997
R44 · FY2020 · DA